SML0414

NCX 4040

≥98% (HPLC)

• Synonym(e): 2-(Acetyloxy)benzoic acid 4-(nitroxymethyl)phenyl ester, NO-aspirin
• Empirische Formel (Hill-System): C₁₆H₁₃NO₇
• CAS-Nummer: 287118-97-2
• Molekulargewicht: 331.28
• MDL-Nummer: MFCD08062164
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329825409
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Lagerbedingungen: protect from light
• Farbe: white to beige
• Löslichkeit: DMSO: 15 mg/mL (clear solution)
• Lagertemp.: −20°C
• SMILES String: CC(=O)Oc1ccccc1C(=O)Oc2ccc(CO[N+]([O-])=O)cc2
• InChI: 1S/C16H13NO7/c1-11(18)23-15-5-3-2-4-14(15)16(19)24-13-8-6-12(7-9-13)10-22-17(20)21/h2-9H,10H2,1H3
• InChIKey: CTHNKWFUDCMLIQ-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

NCX 4040 is a nitric oxide-donating form of aspirin.

NCX 4040 is a nitric oxide-donating form of aspirin. NCX 4040 inhibits cyclooxygenase activity and releases NO, which can down-regulate COX2 expression and reduce the levels of superoxide accumulation. In the human monocytic cell line THP1, the compound inhibits PGE2 production and cytokine expression, and appears to stabilize IkB by inhibiting proteasome function. NCX 4040 has been shown to induce apoptosis in several tumor cell lines.

Leistungsmerkmale und Vorteile

This compound is featured on the Nitric Oxide Synthases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Sicherheitshinweise

• Piktogramme: GHS05,GHS07,GHS09
• Signalwort: Danger
• H-Sätze: H317,H318,H400
• P-Sätze: P273 - P280 - P302 + P352 - P305 + P351 + P338 + P310
• Gefahreneinstufungen: Aquatic Acute 1 - Eye Dam. 1 - Skin Sens. 1
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable